This inventor holds 8 USPTO granted patents and 1 published patent application. Top assignees: Syntex (u.s.a.) Inc., Sri International. Active years: 1979-1997.
Company Filing History:
Years Active: 1979-1997
Title: Helen Y Wu: A Trailblazer in Pharmaceutical Innovations
Introduction
Helen Y Wu is a prominent inventor based in San Jose, CA, known for her significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 8 patents, she has made strides in developing novel compounds that have the potential to impact various therapeutic areas.
Latest Patents
Among her latest patents, Helen has developed innovative compounds such as 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy-pyridine. This invention relates to novel α1-adrenoceptor antagonists of Formula I, which are crucial for advancing treatment options. Additionally, she has worked on nucleoside compounds of Formula I, wherein B is a purine or a pyrimidine, showcasing her versatility in pharmaceutical research.
Career Highlights
Helen has had a distinguished career, working with notable companies such as Syntex Inc. and SRI International. Her work in these organizations has allowed her to push the boundaries of pharmaceutical science and contribute to the development of groundbreaking therapies.
Collaborations
Throughout her career, Helen has collaborated with esteemed colleagues, including Thomas H Smith and David W Henry. These partnerships have fostered an environment of innovation and have led to the successful development of her patented inventions.
Conclusion
Helen Y Wu stands out as a leading inventor in the pharmaceutical industry, with a strong track record of innovation and collaboration. Her contributions continue to shape the future of medicine and improve patient outcomes.